Publisher
Springer Science and Business Media LLC
Reference5 articles.
1. Davis HE, McCorkell L, Vogel JM, Topol EJ, Long COVID (2023) major findings, mechanisms and recommendations [published correction appears in Nat Rev Microbiol. ;21(6):408]. Nat Rev Microbiol. 2023;21(3):133–146
2. Tziolos NR, Ioannou P, Baliou S, Kofteridis DP (2023) Long COVID-19 pathophysiology: what do we know so far? Microorganisms 11(10):2458
3. Ali AE, Awad MK, Ali K, Abouzid MR, Ahmed MH, Mazroua MS Factor XI as a new target for prevention of thromboembolism in cardiovascular disease: a meta-analysis of randomized controlled trials. J Thromb Thrombolysis
4. Schuermans A, Verstraete A, Lammi V et al (2024) Proteogenomic analyses identify coagulation factor XI as a thromboinflammatory mediator of long COVID. Preprint medRxiv. ;2024.05.17.24307553.
5. Nicolai L, Kaiser R, Stark K (2023) Thromboinflammation in long COVID-the elusive key to postinfection sequelae? J Thromb Haemost 21(8):2020–2031